Close Menu
NEW YORK (GenomeWeb News) – Atlas Genetics has gained £2.1 million ($4.1 million) in venture capital from previous and new investors, which it will use to conduct clinical evaluations for a clinical diagnostic test for Group B Streptococcus in pregnant women.
 
Investors in this round of financing included South West Ventures Fund, GEIF, and private investors through the SWAIN business angel’s network. New investors included Finance South West Growth Fund and Braveheart Ventures.
 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.